How Delhi HC's post-expiry patent revocation ruling could impact India's generic drug market
Illustrative imageThe Delhi High Court's division bench ruling in Boehringer Ingelheim v. Controller of Patents, upholding the maintainability of section 64 revocation petitions even post-patent expiry and alongside section 107 invalidity defenses in …